NCT04647578

Brief Summary

Inflammatory bowel diseases (IBDs), including Crohn's disease (CD), ulcerative colitis (UC) and IBD-unclassified (IBD-U), are characterised by chronic inflammation of the gastrointestinal tract. Over the past 50 years, the incidence of IBD has increased globally, with the highest increase in industrialised countries. During the last 25 years, the incidence of IBD has increased dramatically among teenagers in northern France, with an increase of 126% and 156% for CD and UC, respectively. Physical fitness is a set of attributes related to a person's ability to perform physical activities that require aerobic capacity, endurance, strength or flexibility and is determined by a combination of regular physical activity and genetically inherited ability. Physical fitness, widely recognised as an important health determinant, plays an important role in growth and development. Due to the evidence-based importance of physical fitness for young people's health status, attention should be paid to the assessment of physical fitness at these ages and whatever the health status. At this time, there is no study on the assessment of physical fitness in IBD pediatric patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 24, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 1, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

April 21, 2026

Status Verified

September 1, 2022

Enrollment Period

1.6 years

First QC Date

November 24, 2020

Last Update Submit

April 16, 2026

Conditions

Keywords

PediatricIBDphysical fitness

Outcome Measures

Primary Outcomes (1)

  • Difference in cardiorespiratory fitness (expressed in ml/kg/min) between children and adolescents with IBD and age-, BMI and sex-matched healthy controls.

    At 7 days

Secondary Outcomes (7)

  • Difference in muscular endurance, strength, speed/agility, flexibility, strength between children and adolescents with IBD and age-, BMI and sex-matched healthy controls

    Baseline, at 7 days

  • Disease activity according to PCDAI scores

    Baseline, at 7 days

  • Disease activity according to PUCAI scores

    Baseline, at 7 days

  • Percentage of IBD children and adolescents with a cardiovascular risk disease

    Baseline, at 7 days

  • Correlation between quality of life and physical fitness in children and adolescent with IBD

    Baseline, at 7 days

  • +2 more secondary outcomes

Study Arms (2)

Child with IBD

Device: GT3X Actigraph accelerometer.

Healthy child witnesses

Interventions

GT3X Actigraph accelerometer during 7 days

Child with IBD

Eligibility Criteria

Age10 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Healthy children and adolescents with IBD (Crohn's disease, ulcerative colitis and chronic ulcerative colitis).

You may qualify if:

  • For children with IBD:
  • boy or girl aged 10 to 17 years old when signing the consent.
  • obtain the consent of participation of the child and the signed inform consent of the two parents or a legal representative.
  • Patient benefiting from health care- has IBD (Crohn's disease, ulcerative colitis and unclassified chronic colitis) for at least 6 months.
  • Contactable by phone
  • For healthy controls:
  • Patient without IBD
  • Boy or girl aged 10 to 17 years old when signing the consent.
  • obtain the consent of participation of the child and the signed inform consent of the two parents or a legal representative.
  • Patient benefiting from health care

You may not qualify if:

  • For children with IBD:
  • Patients with a disease a mild activity (PCDAI score \> 30 for children with Crohn disease and PUCAI \> 35 for children with ulcerative colitis.
  • Chronic, acute or intermittent diseases (other than IBD) that may lead to a decrease in physical activity (Example: fracture, paralysis, blindness ...).
  • Refusal of the child's participation in the protocol.
  • Refusal of one of the child's parents to participate in the protocol.
  • Participation in another interventional study.
  • Pregnant or lactating women.
  • Patient under protection of justice.
  • For healthy controls:
  • Chronic, acute or intermittent diseases (other than IBD) that may lead to a decrease in physical fitness and activity (Example: fracture, paralysis, blindness ...).
  • Refusal of the child's participation in the protocol.
  • Refusal of one of the child's parents to participate in the protocol.
  • Participation in another interventional study.
  • Pregnant or lactating women.
  • Patient under protection of justice.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hop Jeanne de Flandre Chu Lille

Lille, 59037, France

Location

Related Publications (1)

  • Vanhelst J, Beghin L, Coopman S, Labreuche J, Djeddi D, Gottrand F, Turck D, Ley D. Physical fitness in children and adolescents with inflammatory bowel disease: protocol for a case-control study. BMJ Open. 2022 Oct 11;12(10):e063403. doi: 10.1136/bmjopen-2022-063403.

MeSH Terms

Conditions

Crohn DiseaseInflammatory Bowel DiseasesColitis, UlcerativeProctocolitis

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesColitisColonic DiseasesProctitisSigmoid DiseasesRectal Diseases

Study Officials

  • Dominique TURCK, MD,PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2020

First Posted

December 1, 2020

Study Start

September 1, 2020

Primary Completion

March 31, 2022

Study Completion

March 31, 2022

Last Updated

April 21, 2026

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will share

Data are available upon reasonable request. Data will be made available following the conclusion of the project's period of funding.

Locations